← Back to Markets

ERNA

Ernexa Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$0.21+$0.00 (+2.05%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for ERNA is being prepared.

Key Stats

Key Stats

Open

$0.20

Day High

$0.22

Day Low

$0.20

Prev Close

$0.21

Volume

0

Avg Volume

917.7K

Day Change

+$0.00

Change %

+2.05%

Fundamentals

Fundamentals

P/B

3.92

EPS (TTM)

$-3.24

Market Cap

$6M

52-Wk Range

$0.18 — $4.02

Earnings History

Insider Activity

Who Owns This Stock

Who Owns ERNA

Other88.3%7 holders
Passive / Index11.5%3 holders

Based on Q4 2025 13F filings + AC behavioral model

14 institutional holders

Top Holders

1.Corient Private Wealth LLC
$525.7B
2.Vanguard Group
+142.9%$30.5B
3.Geode Capital Management
+341.1%$22.3B
4.Vanguard Group
0.0%$12.6B
5.Sippican Capital Advisors
0.0%$12.0B
6.Geode Capital Management
+20.1%$6.1B
7.BlackRock, Inc.
0.0%$984M
8.Fortitude Family Office, LLC
$965M
9.UBS Group AG
$720M
10.ASSETMARK, INC
0.0%$160M
11.Bank of America Corp
+3.1%$40M
12.Morgan Stanley IM
$36M
13.HRT FINANCIAL LP
$15M
0.0%$12M
15.MONTAG A & ASSOCIATES INC
0.0%$10M
16.Activest Wealth Management
0.0%$4M
17.Bank of America Corp
-96.9%$1M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Neutral
Other(88.3%)
Passive / Index(11.5%)
Holds
Dealer / Bank(0.1%)
Facilitating

12% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
Analyst Consensus0 buy, 3 hold, 3 sellFinnhub
↑↑Inst. Flows9 increased/new, 1 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

Data provided by Finnhub. Prices delayed up to 5 minutes.